Observatory of Immunological Thrombopenic Purpura in the Brest Region

Last updated: August 13, 2024
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting

Phase

N/A

Condition

Immune (Idiopathic) Thrombocytopenic Purpura (Itp)

Dysfunctional Uterine Bleeding

Thrombocytopenia And Thrombocytopenia Prevention

Treatment

N/A

Clinical Study ID

NCT06556888
29BRC19.0089
  • All Genders

Study Summary

Database of patients with ITP, diagnosed, treated and followed in the Brest University Hospital.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with ITP agree to participate

Exclusion

Exclusion Criteria:

  • Other thrombocythopenia other than ITP

  • Patients Under guardianship

  • Patients without national social security

Study Design

Total Participants: 500
Study Start date:
June 20, 2019
Estimated Completion Date:
November 30, 2039

Study Description

Creation of a global clinical and biological database for all patients diagnosed, treated and followed for ITP in the University Hospital of Brest.

UHB is the regional reference center (competence center) on hemorrhagic diseases.

Dr Pan-Petesch, who is responsible of the local competence center, is affiliated to the national sector of auto-immune cytopenias CERECAI-MARIH).

Connect with a study center

  • Hematology Department - Institute of Oncology and Hematology, University Hospital of Brest

    Brest, Bretagne 29609
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.